Protia Inc. (KOSDAQ:303360)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,960.00
-80.00 (-1.59%)
At close: Mar 6, 2026
52.85%
Market Cap 60.91B
Revenue (ttm) 13.52B
Net Income (ttm) 3.80B
Shares Out 12.88M
EPS (ttm) 294.87
PE Ratio 16.04
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 26,684
Average Volume 48,258
Open 5,040.00
Previous Close 5,040.00
Day's Range 4,870.00 - 5,040.00
52-Week Range 2,885.00 - 6,890.00
Beta 0.06
RSI 37.91
Earnings Date n/a

About Protia

Protia Inc. manufactures and sells in vitro diagnostic medical devices in South Korea. It offers allergy, animal diagnosis, autoimmune, antibiotic susceptibility, POCT, cancer, and related instrument products, as well as protein analysis, LC-MS/MS, characterization analysis, and custom protein services. The company was formerly known as ProteomeTech Inc. and changed its name to Protia Inc. in November 2023. Protia Inc. was founded in 2000 and is headquartered in Seoul, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2000
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 303360
Full Company Profile

Financial Performance

In 2024, Protia's revenue was 10.51 billion, an increase of 27.79% compared to the previous year's 8.23 billion. Earnings were 2.44 billion, an increase of 427.52%.

Financial Statements

News

There is no news available yet.